The Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, China.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Molecules. 2021 Mar 16;26(6):1648. doi: 10.3390/molecules26061648.
Pyrrolizidine alkaloids (PAs) are a class of natural toxins with hepatotoxicity, genotoxicity and carcinogenicity. They are endogenous and adulterated toxic components widely found in food and herbal products. In this study, a sensitive and efficient ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was used to detect the PAs in 386 kinds of Chinese herbal medicines recorded in the Chinese Pharmacopoeia (2020). The estimated daily intake (EDI) of 0.007 μg/kg body weight (bw)/day was adopted as the safety baseline. The margin of exposure (MOE) approach was applied to evaluate the chronic exposure risk for the genotoxic and carcinogenic potential of PAs. Results showed that PAs was detected in 271 out of 386 samples with a content of 0.1-25,567.4 μg/kg, and there were 20 samples with EDI values above the baseline, 0.007 μg/kg bw/day. Beyond that, the MOE values for 10 out of 271 positive samples were below 10,000. Considering the actual situation, Haber's rule was used to assume two weeks exposure every year during lifetime, and still the MOE values for four out of 271 positive samples were under 10,000, indicating these products may have potential health risk. The developed method was successfully applied to detect the PAs-containing Chinese herbal medicines. This study provides convincing data that can support risk management actions in China and a meaningful reference for the rational and safe use of Chinese herbal medicines.
吡咯里西啶生物碱(PA)是一类具有肝毒性、遗传毒性和致癌性的天然毒素。它们是内源性和掺杂物的有毒成分,广泛存在于食品和草药产品中。在这项研究中,采用了灵敏高效的超高效液相色谱-串联质谱(UPLC-MS/MS)方法来检测《中国药典》(2020 年版)中记载的 386 种中草药中的 PA。采用 0.007μg/kg 体重/天的估计日摄入量(EDI)作为安全基准线。应用暴露量边际(MOE)方法来评估 PA 的遗传毒性和致癌潜力的慢性暴露风险。结果表明,在 386 个样品中有 271 个样品中检测到 PA,含量为 0.1-25567.4μg/kg,有 20 个样品的 EDI 值超过了基准线,即 0.007μg/kg bw/day。此外,在 271 个阳性样品中,有 10 个样品的 MOE 值低于 10000。考虑到实际情况,采用了哈伯规则,假设一生中每年有两周的暴露时间,在 271 个阳性样品中,仍有 4 个样品的 MOE 值低于 10000,表明这些产品可能存在潜在的健康风险。所建立的方法成功地应用于检测含 PA 的中草药。这项研究提供了有说服力的数据,可以支持中国的风险管理行动,并为中草药的合理和安全使用提供了有意义的参考。